Baxter International Inc. (BAX) is in the Health Care Industry

Baxter International operates via three key business segments. Co.'s BioScience business produces recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as proteins used in hemostasis, wound-sealing and tissue regeneration; and vaccines. In addition, Co.'s Medication Delivery business manufactures products used in the delivery of fluids and drugs to patients, and its Renal business provides products to treat end-stage renal disease, or irreversible kidney failure.